Kbc Group Nv Surmodics Inc Transaction History

Kbc Group Nv

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Feb 15, 2024	BUY	$28.84 - $38.92 $31,781 - $42,889	1,102 New	1,102 $34,000
Q2 2022 Feb 14, 2024	SELL	$33.25 - $45.11 $16,891 - $22,915	-508 Reduced 31.55%	1,102 $41,000
Q2 2022 Jul 26, 2022	BUY	$33.25 - $45.11 $36,641 - $49,711	1,102 New	1,102 $41,000
Q1 2022 May 06, 2022	SELL	$40.68 - $49.72 $65,494 - $80,049	-1,610 Closed	0 $0
Q4 2021 Feb 14, 2024	BUY	$43.21 - $57.6 $69,568 - $92,736	1,610 New	1,610 $78,000
Q4 2021 Feb 03, 2022	SELL	$43.21 - $57.6 $159,185 - $212,198	-3,684 Reduced 69.59%	1,610 $78,000
Q2 2021 Aug 11, 2021	SELL	$51.29 - $59.15 $88,988 - $102,625	-1,735 Reduced 24.68%	5,294 $287,000
Q3 2020 Oct 28, 2020	BUY	$37.98 - $48.72 $266,961 - $342,452	7,029 New	7,029 $273,000
Q1 2020 May 04, 2020	SELL	$22.46 - $42.24 $138,061 - $259,649	-6,147 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$39.01 - $47.51 $239,794 - $292,043	6,147 New	6,147 $255,000

128

11.8M

1.4K

8.6K

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $477M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.